LIWANLI Innovation Co., Ltd.

TWSE:3054.TW

21.3 (TWD) • At close September 6, 2024
Bedrijfsnaam LIWANLI Innovation Co., Ltd.
Symbool 3054.TW
Munteenheid TWD
Prijs 21.3
Beurswaarde 1,717,866,300
Dividendpercentage 0%
52-weken bereik 19 - 24.6
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO 0
Website https://www.liwanli.com.tw

An error occurred while fetching data.

Over LIWANLI Innovation Co., Ltd.

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels,

Vergelijkbare Aandelen

GenMont Biotech Incorporation logo

GenMont Biotech Incorporation

3164.TW

22.9 TWD

OK Biotech Co., Ltd. logo

OK Biotech Co., Ltd.

4155.TW

24.35 TWD

Maywufa Company Ltd. logo

Maywufa Company Ltd.

1731.TW

22.65 TWD

Apex Biotechnology Corp. logo

Apex Biotechnology Corp.

1733.TW

29 TWD

Applied BioCode Corporation logo

Applied BioCode Corporation

6598.TW

22.1 TWD

Abnova (Taiwan) Corporation logo

Abnova (Taiwan) Corporation

4133.TW

30.2 TWD

Apex Medical Corp. logo

Apex Medical Corp.

4106.TW

25.45 TWD

SciVision Biotech Inc. logo

SciVision Biotech Inc.

1786.TW

131.5 TWD

Maxigen Biotech Inc. logo

Maxigen Biotech Inc.

1783.TW

45.5 TWD

Nang Kuang Pharmaceutical Co., Ltd. logo

Nang Kuang Pharmaceutical Co., Ltd.

1752.TW

43.8 TWD

Financiële Gegevens

Cijfers zijn in miljoenen (TWD)

Cijfers zijn in miljoenen (TWD)